Tag Archive for: Chief Executive

Working closely with Life Science Partner, the Middle Tennessee Research Institute has recruited Lori A. Gould as its new Executive Director.

Lori Gould, MTRI Executive Director

MTRI:  Not for Profit Research Institute for the Veterans Administration, Nashville TN

Middle Tennessee Research Institute (MTRI), based in Nashville, TN, is a non-profit organization dedicated to advancing research and education for the U.S. Department of Veterans Affairs.

MTRI collaborates with the Tennessee Valley Healthcare System to enhance treatment and educational opportunities for veterans, employing a model established by federal legislation in 1988.

This organization is part of a nationwide network of 83 similar non-profit research organizations.

Executive Director Requirements

MTRI partnered with Life Science Partner to recruit its new Executive Director to drive growth and expand its non-VA funding sources. The key characteristics sought included: 

  • Entrepreneurial leadership with proven skills in organizational management.
  • Financial oversight experience with budgets up to $10 million.
  • Strategic marketing with developing successful promotional campaigns.
  • Management of teams, including recruiting staffing, planning, and budgeting capabilities to enhance research and patient care within the organization.

A Personal and Professional Project

This was both a professional and personal project for Life Science Partner’s Founder, Tom Callaway, MD.  He and his team worked closely with his first cousin, Dr. Carol Callaway-Lane, DNP, ACNP-BC. Callaway-Lane was Board President of Middle Tennessee Research Institute (MTRI), and his medical school classmate, Stokes Peebles, Jr, MD. 

Peebles is on the MTRI Board and is a Professor in the Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, at Vanderbilt University Medical Center. He is the Principal Investigator of The Peebles Lab, which investigates mechanisms regulating lung inflammation.

Tom Callaway commented, “It was a pleasure working with my alma mater and two very close friends to recruit Lori to lead this innovative partnership between the VA and external research funding sources to improve the healthcare of our nation’s veterans. Nashville-based MTRI is a leading not-for-profit research organization and will accelerate its rising status and funding under Lori Gould’s tested leadership and vision.”

Lori Gould Is Recruited to Lead MTRI

Lori Gould was the perfect fit. She was most recently Executive Director of the Veterans Health Research Institute of CNY Inc. (VHRI) in Syracuse, NY, and has demonstrated outstanding leadership and commitment in her roles spanning over thirty years.  Gould’s career is marked by a continuous progression in roles with increasing responsibility, particularly in managing financial and operational systems.

Her leadership qualities, combined with a strong background in finance and technology, have contributed to the growth of the organizations she has worked with, setting a high standard in nonprofit management and operational excellence. Her career trajectory is a testament to her dedication, strategic vision, and capability to adapt and thrive in dynamic environments.

Lori Gould’s Leadership Spotlight

Since September 2010, Gould has led VHRI, a multi-site non-profit corporation (NPC) serving the Syracuse VA Medical Center and the Finger Lakes Health Care System. As Executive Director, she has effectively managed the overall operations, ensuring compliance with board directives and applicable federal and state requirements.

Her leadership spans various critical functions, including financial management, human resources, and grant administration. Gould’s ability to negotiate Cooperative Research and Development Agreement (CRADA) terms and maintain a robust pool of research coordinators exemplifies her strategic foresight and operational excellence. She has represented VHRI at various significant meetings and has solidified the organization’s position within the community.

Before this role, from September 2006 to September 2010, Gould served as the Chief Financial Officer for the same institute. Her responsibilities included overseeing all accounting functions, ensuring compliance with relevant regulations, and managing VHRI’s fiscal performance. Her strategic development of annual operating budgets and oversight of clinical trial and federal grant budgets highlight her adeptness in financial governance and resource allocation.

Between September 2005 and June 2006, Gould enriched her career portfolio as a Staff Accountant at the Diocese of Syracuse.   From October 2001 to June 2002, Gould was the Manager of Technology & Analysis at Agri-Services Agency LLC, East Syracuse, NY. She designed and implemented a new technology system to meet the company’s present and future needs, showcasing her foresight in technological integration and system management.

Gould’s contributions included revamping the accounting and billing systems and implementing collection procedures that notably reduced the receivable balance, reflecting her impact on streamlining financial operations.

Gould’s Early Career Highlights

Earlier in her career, from June 1996 to November 1997, Gould served as the Purchasing Manager at Applied Theory Communications, where she established a new purchasing department and significantly reduced expenses through strategic vendor agreements.

Her Financial/Budget Analyst role at Chesterton Company from June 1993 to November 1995 further highlights her expertise in financial analysis and budget management.

The early years of her career were spent as a Fiscal Manager at Broome BOCES – RIC in Binghamton, NY, from July 1986 to January 1993

Gould began her professional journey after graduating with a B.S. in Business Administration/Finance from the Rochester Institute of Technology in 1986.

Life Science Partner – Recruiting Transformational Leaders Like Gould

Since 2002, Life Science Partner has combined scientific knowledge with business discipline to identify and recruit the brightest talent, provide strategic advice, and connect companies with the best candidates to make their enterprises more successful.

Our targeted, high-quality executive search services meet the specific needs of medical device, biotechnology, pharmaceutical, and healthcare organizations.

How LSP Recruits Differently – Through Partnership

Life Science Partner has designed a unique and thorough approach to bringing our clients the transformational leaders needed to take their businesses to the next level.

Life Science Partner will work with your organizational needs, including the corporate culture and factors for success in the role, in order to:

  • Create a job description that captures the opportunity to attract the best and most qualified talent.
  • Strategically research, identify, and contact prospective candidates and sources.
  • Assess our best prospective candidates via telephone, Zoom, and face-to-face interviews.
  • Update you with continuous feedback on our progress in weekly meetings, written reports, and telephone calls.
  • Provide you with candidate assessment letters that convey our recommendations and reservations.
  • Conduct in-depth references on the leading candidates with a written report.
  • Assist you in negotiating an acceptable offer, with a fiduciary responsibility to our client.
  • Partner with you to ensure a successful transition into the new role, including a one-year search-again guarantee of success.

Happy Client and Its New Leader

With the recruitment of Lori Gould to lead the Nashville-based Middle Tennessee Veterans Research Institute, Life Science Partner again has demonstrated its proven formula can deliver results and provide organizations with transformative leaders. 

Congratulations to our client, Dr. Carol Callaway-Lane, DNP, ACNP-BC, Board President, and her new Executive Director, Lori Gould.

Life Science Partner announces the recruitment of Stewart McNaull, PhD, to develop commercialization and expand access of Wheeler Bio’s products and service offerings.

Stewart McNaull

Wheeler Bio, a quickly growing CDMO, retained Life Science Partner to recruit their President and Chief Operating Officer in 2022 to accelerate their advancement as an industry leader in biologics development services. After a thorough search, the company hired a seasoned executive to lead their strategic business opportunities and joint ventures. Early in 2023, Wheeler Bio contacted Life Science Partner to repeat the search to better fulfill the needs of the company.

As a result of reconvening the search and in partnership with the Wheeler Bio Board, Life Science Partner recruited Stewart McNaull, PhD, former Vice President and Business Unit Head, Biologics and Vaccines for Resilience, to serve as Wheeler’s Senior Vice President, Chief Business Officer.

With his extensive commercial experience in the CDMO industry, McNaull will have a tremendous impact on the establishment of Wheeler’s strategic alliances and sales channel development.”

Tom Callaway, MD, Founder of Life Science Partner.

While at Resilience, McNaull managed the business operations and strategy for the Biologics and Vaccines commercial franchise encompassing seven development and manufacturing sites worldwide. Leading the design and execution of the company’s network development and sales/marketing strategy, McNaull was successful in spear-heading rapid growth and expansion of the company’s Biologics and Vaccines business.

Prior to his role at Resilience, McNaull served as Senior Vice President, Business Development for KBI Biopharma where he had global responsibility for the company’s sales and marketing strategy. Earlier in his career, McNaull served in business development and scientific engineering leadership roles for Diosynth Biotechnologies and Bayer Biologics.

McNaull received his Bachelor of Science degree in Chemical Engineering from North Carolina State University and his PhD in Chemical Engineering from the Georgia Institute of Technology.

Life Science Partner shares an inside conversation of their recruitment partnership with advanced biologics CDMO, Wheeler Bio.

In the fall of 2022, Jesse McCool, PhD, Founder and CEO and the Board of Directors of Wheeler Bio retained Life Science Partner to recruit their new President and Chief Operating Officer.  In partnership with Dr. McCool, Life Science Partner identified, qualified, and recruited Roger Lias, PhD, an industry veteran who was most recently Chief Operating Officer of Vibalogics.

Tom Callaway, MD, Founder of Life Science Partner, sat down with McCool and Lias to discuss Wheeler’s advancements in the Contract Development and Manufacturing Operation (CDMO) market and converse on the two sides of the candidate/client recruitment process.

Wheeler Bio continues their close relationship with Life Science Partner, having additionally recruited their Chief Development Officer, Brian Berquist, PhD, to accelerate their platform and emerge as a technological leader within the CDMO space.

Contact Life Science Partner to build out your transformational leadership team.

Life Science Partner announces the recruitment of Detra Glinatsis to lead Alloy Therapeutics’ enterprise sales growth within the CDMO industry.

Alloy Therapeutics retained Life Science Partner to recruit their Vice President, Business Development and Sales to manage and accelerate their growth in biologics development services. Through a community of over 100 partners and developers, Alloy seeks to democratize access to pre- competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics.

Detra Glinatsis

Life Science Partner is pleased to announce that Detra Glinatsis, former Senior Director, Business Development from AGC Biologics with experience building and leading a sales organization, will lead Alloy Therapeutics sales team.

“As a resourceful self-starter with a talent for streamlining sales processes, Glinatsis will be an instrumental addition for supporting Alloy Therapeutics’ rapid growth within the CDMO space.”

Tom Callaway, MD, Founder of Life Science Partner

In her new role at Alloy, Glinatsis will lead a team to build out the company’s customer base and sales infrastructure. She will identify and manage strategic partnerships, alliances, and joint ventures to contribute to Alloy’s expansion within the market. Additionally, Glinatsis will have the responsibility to facilitate Alloy’s participation in industry events, creation of collateral materials, and marketing of Alloy’s position within the CDMO space.

Prior to joining Alloy, Glinatsis served in various global business development roles for CDMOs and pharmaceutical companies including AGC Biologics, Sartorius, Rentschler Biopharma, Inventiv Health and Patheon Biologics. She holds a Bachelor of Science Degree in Biology from the University of Akron.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner announces the recruitment of Roger Lias, PhD, to Wheeler Bio to advance their expansion as cutting-edge biologics CDMO.

Roger Lias Wheeler Bio

Wheeler Bio, a CDMO, retained Life Science Partner to recruit their President and Chief Operating Officer to accelerate their growth as an industry leader in biologics development services. With a new state-of-the-art Oklahoma City facility, Wheeler Bio has revolutionized the speed of drug discovery with their novel hub-and-spoke concept and Portable CMC® platform that fast-tracks the pathway to IND.

After a nationwide search campaign, Roger Lias, PhD, former Chief Commercial Officer of Vibalogics, was recruited by Life Science Partner to serve as Wheeler Bio’s President and Chief Operating Officer beginning in September 2022.

Lias’ well-established credibility in the biopharma CDMO industry combined with his entrepreneurial leadership experience made him an absolute fit for growing Wheeler Bio into the global partner of choice for biological companies.”

Tom Callaway, MD, Founder of Life Science Partner

Lias will hit the ground running joining the Wheeler Bio team at the BioProcess International Conference in Boston this month, September 2022. In his new role Lias will be responsible for spearheading strategic business opportunities, alliances and joint ventures and will lead a scalable business operations team keeping Wheeler’s technology development and functions aligned with the corporate strategy as industry demand increases.

Prior to joining Wheeler Bio, Lias served as the Chief Commercial Officer for Vibalogics, a Private Equity-backed CDMO that was acquired by Recipharm AB in February, 2022.  He has an extensive track record of entrepreneurial successes including Stelis Biopharma, Avid Biosciences, Allergan, Eden Pharma, Cytovance and KBI Biopharma.

Lias holds a Bachelor of Science degree in Physiology and Biochemistry from the University of Southampton in the United Kingdom. He earned his PhD from Clare College, University Cambridge.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner announces the recruitment of Mark Bogart to serve as Senior Vice President, US Healthcare for B-Secur, a global leader in accelerating the quality of EKG signals to create highly accurate analytics for digital heart health.

Life Science Partner served as a strategic consulting and executive search partner of B-Secur to support their U.S. launch of their signature SaaS technology, HeartKey 2.0®.

Mark Bogart

This cloud-based solution will accelerate the convergence of medical and consumer health devices by offering a proprietary conditioning, FDA-cleared software to improve health algorithms and wellness insights. B-Secur’s innovative biosensing algorithms refine and enhance signal clarity on micro processing chips (implantable or wearable), for consumer technology partner servers providing novel insights. Their technology also serves as an adjunctive tool for accelerating the adoption of medical device company’s proprietary and patient-centric solutions.

With B-Secur’s technology in high demand to improve signal quality, Bogart will secure and expand relationships with US-based medical device and digital health providers. Additionally, Bogart will build and lead the team to grow the US commercialization opportunities with leading cardiac device companies seeking to bring their EKG monitoring solutions to ambulatory and at-home patients.

“With his subject-matter expertise in digital healthcare and remote patient monitoring combined with his exceptional career as a sales leader, Bogart is well-suited to accelerate B-Secur’s growth and establishment within the US market.”

Tom Callaway, MD, Founder of Life Science Partner

Bogart joins B-Secur after serving as Senior Vice President, US Healthcare for AliveCor, a medical device company that produces ECG hardware and software for mobile devices. Bogart led the healthcare division’s go-to-market strategy spear heading critical partnerships and novel acquisitions during his tenure. Earlier in his career, Bogart served in revenue-generating business development leadership roles at companies such as G Medical Innovations, Viterion Corporation, LifeWatch, ZOLL Medical and Boston Scientific.

Bogart holds a Bachelor of Arts degree in Economics and Political Science from Lake Forest College.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner is pleased to announce the recruitment of Stan Harris as Vice President, Clinical Operations for BioTissue – the newly unified brand for TissueTech, Amniox, and Bio-Tissue.

BioTissue is an emerging biotechnology leader in utilizing the power of human birth tissue for regenerative healing to treat ocular surface disease and in surgical, chronic wound, and musculoskeletal applications.

Stan Harris

“For years, health care professionals have known our products—regardless of their specific applications—for providing mother nature’s most natural gift of healing so their patients can get back to the lives they love,” said Ted Davis, president, and CEO, BioTissue. “Our new, unified brand supports our entire pipeline of human birth tissue products to aid the treatment of wounds, musculoskeletal conditions, trauma-induced injuries, ocular surface disease, and burns.”

With nearly 40 years dedicated to the medical device industry and a focus on regulatory, quality, and clinical affairs, Harris brings a wealth of knowledge and experience to the clinical operations team at BioTissue. The FDA and other global regulatory agencies are increasing the regulatory oversight of cell-derived therapies.  Harris will be responsible for developing and leading BioTissue’s clinical development with an emphasis in the ophthalmology, orthopedic and pain management indications.

Most recently Harris served as the Vice President, Regulatory, Clinical and Quality Affairs at Lifeline Scientific with previous clinical and regulatory roles at MiMedx, Integra Life Sciences, Ascension Orthopedics, and Wright Medical. “From his previous experience, Harris has direct relationships with key thought leaders in wound healing including excellent relations with the FDA, US, and European regulatory agencies for biological products,” states Tom Callaway, MD, MBA, Founder of Life Science Partner. “His experiences and enthusiasm will be ideal for BioTissue’s continued growth and product development.”

Harris earned a bachelor’s degree in biology from Mercer University. He completed Graduate Studies in Biotechnologies from the Georgia Institute of Technology. 

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds in medicine, science, and industry enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner has recruited Tom Afzal to become Chief Executive Officer and Board Member of Novum Medical.

Novum Medical is a private, medical device and orthopedics company developing advanced orthobiomaterials that are structurally sound and compatible to the body. Having shown success with their current applications in extremities, the company is entering the spine industry with their first cervical implant device (currently in FDA IDE clinical trials). The technology has already shown promising and superior results when compared to other implants such as titanium or PEEK plastic.

Tom Afzal

Afzal is a leader in the spine, orthopedic and cardiovascular industries. He will lead Novum in transforming the spine surgery and orthopedic markets, while continuing the growth of the company. As a co-Founder and former Chief Executive Officer of Spinal Kinetics, Afzal brought his company to profitability and led the commercial strategy for their artificial discs. He also gained extensive experience building international businesses across Europe, raising sales to over 60,000 implants in over 20 countries.

Prior to Spinal Kinetics, Afzal was the Chief Executive Officer of Cardiovention. He raised $45 M from venture capital firms, established U.S., German, and Swiss sales organizations, filed his own patents, and helped create a team to develop minimally invasive products for cardiovascular surgery.

Afzal spent the early 90s working overseas in Germany for Life System Medizintechnik and Krauth Medical, achieving annual revenue growth and leading Life System through its acquisition by Krauth Medical. He graduated from San Diego State University majoring in Business Administration and minoring in Finance.

Afzal will play a critical role in raising funds for Novum Medical with his financing background and connections in the spine, cardiovascular and sports medicine industries. As the company completes its FDA IDE clinical trials for their Vitrium cervical interbody spinal fusion device, Afzal will leverage his strengths in commercial and operational leadership to advance the company to its next level of growth.

Novum Medical is a private, medical device and orthopedics company developing advanced orthobiomaterials that are structurally sound and compatible to the body. Having shown success with their current applications in extremities, the company is entering the spine industry with their first cervical implant device (currently in FDA IDE clinical trials). The technology has already shown promising and superior results when compared to other implants such as titanium or PEEK plastic.

Afzal is a leader in the spine, orthopedic and cardiovascular industries. He will lead Novum in transforming the spine surgery and orthopedic markets, while continuing the growth of the company. As a co-Founder and former Chief Executive Officer of Spinal Kinetics, Afzal brought his company to profitability and led the commercial strategy for their artificial discs. He also gained extensive experience building international businesses across Europe, raising sales to over 60,000 implants in over 20 countries.

Prior to Spinal Kinetics, Afzal was the Chief Executive Officer of Cardiovention. He raised $45 M from venture capital firms, established U.S., German, and Swiss sales organizations, filed his own patents, and helped create a team to develop minimally invasive products for cardiovascular surgery.

Afzal spent the early 90s working overseas in Germany for Life System Medizintechnik and Krauth Medical, achieving annual revenue growth and leading Life System through its acquisition by Krauth Medical. He graduated from San Diego State University majoring in Business Administration and minoring in Finance.

Afzal will play a critical role in raising funds for Novum Medical with his financing background and connections in the spine, cardiovascular and sports medicine industries. As the company completes its FDA IDE clinical trials for their Vitrium cervical interbody spinal fusion device, Afzal will leverage his strengths in commercial and operational leadership to advance the company to its next level of growth.

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds in medicine, science, and industry enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner is pleased to announce the recruitment of Gail Farnan as General Manager, Wound Care for Vivex Biologics.

Vivex Biologics, a leading regenerative medicine company that markets tissue technology products and cellular therapies focused on orthopaedic applications with an emphasis on spine related therapies, has developed a diverse portfolio of current products including cellular bone matrices, amniotic tissue, general orthopaedic treatments, and sports medicine products to meet the therapeutic demand in the areas of spine, dental, sports medicine, and wound care. 

The company has a robust Wound Care division that supports their Cygnus products, amniotic derived regenerative allografts used for tissue regeneration and healing.

Gail Farnan

As the company continues to grow its wide array of therapies, it needed a strategic leader who could take charge of one of their franchises. The recruitment of Farnan as General Manager, Wound Care will bring highly focused branding campaigns for the company’s sales forces.

Farnan was the Global Director of Marketing at Medtronic where she guided business development activities for a minimally invasive circulatory support platform called CircuLite. She influenced the education and training of senior leadership on the CircuLite platforms and modeled new global opportunities using qualitative and quantitative market research.

Before Medtronic, she was the Vice President of Marketing at Abiomed where she implemented new marketing strategies for the launches of their Impella platform. She was pivotal in raising U.S. market awareness and presence for the company’s corporate acquisition. Prior to Abiomed, Farnan was the Director of Global Marketing for Novoste Corporation and a Product Marketing Manager at Johnson & Johnson’s Cordis Corporation.

Farnan is a registered nurse by training who developed into a business leader that transformed the marketing landscape of the companies in her wake. Her arrival to Vivex Biologics will improve the Wound Care division with new leadership, strategies and communication tools. With this, the company plans for continued progress in the biologics space.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner is pleased to announce the recruitment of Ron Hebert as Vivex Biologics’ Vice President of Marketing.

Vivex Biologics, a leading regenerative medicine company that markets tissue technology products and cellular therapies. They focus on orthopaedic applications with an emphasis on spine related therapies, and have developed a diverse portfolio of current products including cellular bone matrices, amniotic tissue, general orthopaedic treatments, and sports medicine products to meet the therapeutic demand in the areas of spine, dental, sports medicine, and wound care.

The next stage of the company’s growth is the launch of its new product, VIA Disc.

Ron Herbert

This viable allograft is delivered by a minimally invasive procedure and will be used for the treatment of Degenerative Disc Disease (DDD). As the company continues to grow in the spine and biologics space, it sought a talented Vice President, Marketing who could lead the branding campaigns and support the efforts of the geographic and product-focused sales forces.

Hebert was the Vice President, Marketing, Communications, and Growth Initiatives at MEDNAX, a physician-led healthcare organization that partners with hospitals and health systems to provide a wide range of clinical services. Coming into one of the largest physician-owned/operated national staffing companies, Hebert refocused the company strategy to the hospital-customer and provided them with proof of value. He also created programs that productized services such as women/children, anesthesia, and ENT/plastics specialists.

He also spent a majority of his marketing career at Beckman Coulter serving as Director of Global Strategic Marketing and Global Product Management and Strategy. Hebert’s notable accomplishment during his time here was being able to provide innovation within the traditional product portfolio of the hematology unit.

With the arrival of Hebert, Vivex will gain a marketing leader, an integrative thinker that focuses on the customer needs, a person with a demonstrated track record of successful product launches, and a strong communicator. By utilizing Hebert’s expertise in hospital-based marketing, Vivex Biologics hopes for continued growth of its new products and a skilled manager of its existing lines.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.